Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Lexeo Therapeutics, Inc. (LXEO)

NASDAQ

$4.72

$-0.10

(-2.07%)

Pre-Market

Lexeo Therapeutics, Inc. (LXEO) Live Price Chart

Last updated: ⁦2026-09-09 10:37:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Lexeo Therapeutics, Inc. (LXEO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $4.73, with a market capitalization of $401.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.99 to $10.99. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$401.21M
Open	$4.83
Day's High	$22.33
Day's Low	$1.45
Previous Close	$4.76
Volume	242.00
Average Volume	920.29K
P/E Ratio	--
52-Week High	$10.99
52-Week Low	$3.99
Dividend Yield	--
Earnings Date	--

Lexeo Therapeutics, Inc. (LXEO) Pre-Market Stock Price

Lexeo Therapeutics, Inc. (LXEO) is trading at $4.73 in pre-market trading as of 2026-09-09 08:36:00, down 0.74% ($0.04) from the previous close of $4.76

Pre-market trading shows how investors are pricing LXEO before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Lexeo Therapeutics, Inc. (LXEO) 7-Day Stock Price Change

Over the past seven days, Lexeo Therapeutics, Inc. (LXEO) moved from $4.86 to $4.73, representing a decline of 2.78% ($0.14).

The stock traded between $4.56 and $4.99 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 427.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

LXEO 52-Week Price Position

Position in Range: 10.5%

52W Low$3.99

52W High$10.99

LXEO is currently trading at $4.73, placing it 10.5% of the way from its 52-week low of $3.99 to its 52-week high of $10.99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lexeo Therapeutics, Inc. (LXEO)?

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Lexeo Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	59
Exchange	NASDAQ
Company Website	https://www.lexeotx.com

How to Buy Lexeo Therapeutics, Inc. (LXEO) Stock on MEXC

Eligible investors can buy real shares of Lexeo Therapeutics, Inc. (LXEO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LXEO and Place Your Order

Open the RealStocks trading page and search for LXEO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lexeo Therapeutics, Inc. (LXEO) stock price today?

Lexeo Therapeutics, Inc. (LXEO) is currently trading at $ 4.73, down 0.74% ($0.04) from the previous close of $ 4.76. Intraday prices update in real time during regular trading hours.

2.Is LXEO stock going up or down today?

As of 2026-09-09 08:36:00, LXEO is trading at $ 4.73, down 0.74% ($0.04) from its previous close of $ 4.76. The stock has traded between $ 1.45 and $ 22.33 during today’s regular session. Past price movements do not guarantee future results.

3.What is LXEO pre-market price?

As of 2026-09-09 08:36:00, LXEO is trading at $ 4.73 in pre-market trading, down 0.74% ($0.04) from the previous close of $ 4.76. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LXEO after-hours price?

As of 2026-09-09 08:36:00, LXEO is trading at $ 4.85 in after-hours trading, up 1.79% ($0.08) from the regular-session close of $ 4.76. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LXEO stock trading now?

LXEO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LXEO sit relative to its 52-week high and low?

Over the past 52 weeks, LXEO has traded between a low of $ 3.99 and a high of $ 10.99. At $ 4.73, the stock is positioned 10.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lexeo Therapeutics, Inc. in?

Lexeo Therapeutics, Inc. (LXEO) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lexeo Therapeutics, Inc.'s market capitalization and where is it listed?

Lexeo Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 401.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LXEO valued in terms of P/E ratio and EPS?

LXEO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.06. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lexeo Therapeutics, Inc. pay a dividend?

Lexeo Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.